{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T19:27:47Z","timestamp":1740166067451,"version":"3.37.3"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T00:00:00Z","timestamp":1545004800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","award":["175031","175087"],"award-info":[{"award-number":["175031","175087"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1007\/s13760-018-01064-5","type":"journal-article","created":{"date-parts":[[2018,12,17]],"date-time":"2018-12-17T05:51:45Z","timestamp":1545025905000},"page":"473-474","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bilateral horizontal gaze palsy in benign multiple sclerosis"],"prefix":"10.1007","volume":"120","author":[{"given":"Vanja","family":"Martinovic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Nikolic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarlota","family":"Mesaros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jelena","family":"Drulovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,17]]},"reference":[{"issue":"2","key":"1064_CR1","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1136\/jnnp.70.2.252","volume":"70","author":"D Milea","year":"2001","unstructured":"Milea D, Napolitano M, Dechy H, Le Hoang P, Delattre J-Y, Pierrot-Deseilligny C (2001) Complete bilateral horizontal gaze paralysis disclosing multiple sclerosis. J Neurol Neurosurg Psychiatry 70(2):252\u2013255. \nhttps:\/\/doi.org\/10.1136\/jnnp.70.2.252","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"1064_CR2","first-page":"124","volume":"10","author":"E Tan","year":"1990","unstructured":"Tan E, Kansu T (1990) Bilateral horizontal gaze palsy in multiple sclerosis. J Clin Neuroophthalmol 10(2):124\u2013126","journal-title":"J Clin Neuroophthalmol"},{"key":"1064_CR3","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1177\/1352458513518627","volume":"20","author":"S Kipfer","year":"2014","unstructured":"Kipfer S, Crook DW (2014) Isolated bilateral horizontal gaze palsy as first manifestation of multiple sclerosis. Mult Scler 20:754\u2013755. \nhttps:\/\/doi.org\/10.1177\/1352458513518627","journal-title":"Mult Scler"},{"key":"1064_CR4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1148\/rg.331125033","volume":"33","author":"YJ Bae","year":"2013","unstructured":"Bae YJ, Kim JH, Choi BS, Jung C, Kim E (2013) Brainstem pathways for horizontal eye movement: pathologic correlation with MR imaging. Radiographics 33:47\u201359. \nhttps:\/\/doi.org\/10.1148\/rg.331125033","journal-title":"Radiographics"},{"issue":"4","key":"1064_CR5","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1212\/WNL.46.4.907","volume":"46","author":"FD Lublin","year":"1996","unstructured":"Lublin FD, Reingold SC (1996) Defining the clinical course of multiple sclerosis: results of an international survey. National multiple sclerosis society (USA) advisory committee on clinical trials of new agents in multiple sclerosis. Neurology 46(4):907\u2013911. \nhttps:\/\/doi.org\/10.1212\/WNL.46.4.907","journal-title":"Neurology"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-018-01064-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13760-018-01064-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-018-01064-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T17:46:23Z","timestamp":1584726383000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13760-018-01064-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,17]]},"references-count":5,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["1064"],"URL":"https:\/\/doi.org\/10.1007\/s13760-018-01064-5","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"type":"print","value":"0300-9009"},{"type":"electronic","value":"2240-2993"}],"subject":[],"published":{"date-parts":[[2018,12,17]]},"assertion":[{"value":"18 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Jelena Drulovic: serves on scientific advisory boards for Bayer Schering Pharma, Merck Serono, TEVA, Sanofi Genzyme and received honoraria for speaking from Merck Serono, Teva, Bayer Schering, Sanofi Genzyme, Medis. She is the principal investigator in clinical trials for Merck Serono, Teva, Biogen Idec, Roche, Genzyme, a Sanofi Company, Receptos. Sarlota Mesaros: speaker\u2019s honoraria for Merck Serono and Novartis, travel grants from Bayer and Genzyme a Sanofi. Vanja Martinovi\u0107 declares that she has no conflict of interest. Ivan Nikolic declares that he has no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study were in accordance with ethical standards and approved by the Institutional Review Board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from a patient included in the case-report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}